Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Bianco, María V ^a   Blanco, Federico C ^a   Imperiale, Belén ^b   Forrellad, Marina A ^a   Rocha, Roxana V ^a   Klepp, Laura I ^a   Cataldi, Angel A ^a   Morcillo, Nora ^b   Bigi, Fabiana ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Hospital Zonal de Agudos y Cronicos Dr Antonio A Cetrangolo   (Argentina)

Author keywords

Mycobacterium tuberculosisl; P27; P55; PrG

Indexed keywords

CHEMICAL COMPOUND; DODECYL SULFATE SODIUM; ETHAMBUTOL; ETHIDIUM BROMIDE; ISONIAZID; MALACHITE GREEN; PROTEIN P27; PROTEIN P55; RESERPINE; RIFAMPICIN; TOXIN; TUBERCULOSTATIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; ETHIDIUM; FUCHSINE; LIPOPROTEIN; P27 PROTEIN, MYCOBACTERIUM; P55 PROTEIN, MYCOBACTERIUM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DECOLORIZATION; GENE DELETION; GENE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; P27 GENE; P55 GENE; PHENOTYPE; PROTEIN DEPLETION; SUSPENSION; WILD TYPE; CELL MEMBRANE; CELL SURVIVAL; CELL WALL; CHEMISTRY; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL MEMBRANE; CELL SURVIVAL; CELL WALL; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHAMBUTOL; ETHIDIUM; ISONIAZID; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OPERON; ROSANILINE DYES; SODIUM DODECYL SULFATE;

EID: 79960560920     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-195     Document Type: Article

References (26)

1. The Current Status of TB in the World. The Art & Science of Tuberculosis Vaccine Development 2011, Chapter 2:18-29. Selangor Darul Ehsan: Oxford Fajar Sdn. Bhd, Mohd Nor N, Acosta A, Sarmiento ME, 2.
2. Kirschner DE, Young D, Flynn JL. Tuberculosis: global approaches to a global disease. Curr Opin Biotechnol 2010, 21:524-523. 10.1016/j.copbio.2010.06.002, 20637596.
3. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003, 16:463-496. 10.1128/CMR.16.3.463-496.2003, 164219, 12857778.
4. Bigi F, Alito A, Romano MI, Zumarraga M, Caimi K, Cataldi A. The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis . Microbiology 2000, 146:1011-1018.
5. Bigi F, Gioffré A, Klepp L, Santangelo MP, Alito A, Caimi K, Meikle V, Zumárraga M, Taboga O, Romano MI, Cataldi A. The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis. Microbes Infect 2004, 6:182-187. 10.1016/j.micinf.2003.10.010, 14998516.
6. Ramón-García S, Martín C, Thompson CJ, Aínsa JA. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother 2009, 53:3675-3682. 10.1128/AAC.00550-09, 2737831, 19564371.
7. Silva PE, Bigi F, Santangelo MP, Romano MI, Martín C, Cataldi A, Aínsa JA. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2001, 45:800-804. 10.1128/AAC.45.3.800-804.2001, 90377, 11181364.
8. Bigi F, Espitia C, Alito A, Zumarraga M, Romano MI, Cravero S, Cataldi A. A novel 27 kDa lipoprotein antigen from Mycobacterium bovis. Microbiology 1997, 143:3599-35605. 10.1099/00221287-143-11-3599, 9387238.
9. González-Zamorano M, Mendoza-Hernández G, Xolalpa W, Parada C, Vallecillo AJ, Bigi F, Espitia C. Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of mannosylated proteins. J Proteome Res 2009, 8:721-733. 10.1021/pr800756a, 19196185.
10. Farrow MF, Rubin EJ. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J Bacteriol 2008, 190:1783-1791. 10.1128/JB.01046-07, 2258667, 18156250.
11. Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, Sacchettini JC, Harding CV. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol 2010, 17:1088-1095. 10.1038/nsmb.1869, 2933325, 20694006.
12. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol 2004, 15:2660-2668.
13. Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol 2009, 258:29-37. 10.1016/j.cellimm.2009.03.008, 2730726, 19362712.
14. Carroll MV, Sim RB, Bigi F, Jäkel A, Antrobus R, Mitchell DA. Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG. Protein Cell 2010, 1:859-870. 10.1007/s13238-010-0101-3, 21203928.
15. Hovav AH, Mullerad J, Davidovitch L, Fishman Y, Bigi F, Cataldi A, Bercovier H. The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. Infect Immun 2003, 71:3146-3154. 10.1128/IAI.71.6.3146-3154.2003, 155707, 12761093.
16. Sieling PA, Hill PJ, Dobos KM, Brookman K, Kuhlman AM, Fabri M, Krutzik SR, Rea TH, Heaslip DG, Belisle JT, Modlin RL. Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation. J Immunol 2008, 180:5833-5842. 2710377, 18424702.
17. Banaei N, Kincaid EZ, Lin SY, Desmond E, Jacobs WR, Ernst JD. Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green. Antimicrob Agents Chemother 2009, 53:3799-37802. 10.1128/AAC.00647-09, 2737861, 19596883.
18. Sulzenbacher G, Canaan S, Bordat Y, Neyrolles O, Stadthagen G, Roig-Zamboni V, Rauzier J, Maurin D, Laval F, Daffé M, Cambillau C, Gicquel B, Bourne Y, Jackson M. LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J 2006, 25:1436-1444. 10.1038/sj.emboj.7601048, 1440309, 16541102.
19. Howard NS, Gomez JE, Ko C, Bishai WR. Colour selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector. Gene 1995, 166:181-182. 10.1016/0378-1119(95)00597-X, 8529888.
20. Martin A, Morcillo N, Lemus D, Montoro E, Telles MA, Simboli N, Pontino M, Porras T, León C, Velasco M, Chacon L, Barrera L, Ritacco V, Portaels F, Palomino JC. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2005, 9:901-906.
21. Pontino MV, Di Giulio B, Fernandez C, Imperiale B, Bodon A, Morcillo N. Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis. Rev Arg Microbiol 2006, 38:145-151.
22. Morcillo N, Imperiale B, Di Giulio B. Evaluation of MGI 960 and the colorimetric-based method for tuberculosis drug susceptibility testing. Int J Tuberc Lung Dis 2010, 14:1169-1175.
23. Jones JJ, Falkinham JO. Decolorization of malachite green and crystal violet by waterborne pathogenic mycobacteria. Antimicrob Agents Chemother 2003, 47:2323-2326. 10.1128/AAC.47.7.2323-2326.2003, 161881, 12821489.
24. Piddock LJ, Ricci V. Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis. J Antimicrob Chemother 2000, 45:681-684. 10.1093/jac/45.5.681, 10797093.
25. Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazbón MH, Harbacheuski R, Megjugorac NJ, Jacobs WR, Holzenburg A, Sacchettini JC, Alland D. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol 2005, 55:1829-1840. 10.1111/j.1365-2958.2005.04510.x, 15752203.
26. Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, Wang H. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb Drug Resist 2008, 14:7-11. 10.1089/mdr.2008.0772, 18321205.